> >

AstraZeneca: FDA Approves Faslodex With Abemaciclib For Advanced Breast Cancer Wednesday, 15 November 2017
LONDON (dpa-AFX) - British drug maker AstraZeneca plc (AZN.L, AZN) said that the US Food and Drug Administration or FDA has approved a new indication for Faslodex or fulvestrant, expanding the ind...
Share on
Share on
Post on 
Share by

You Might Like

Tweets about this

Other recent news in Markets

The Obamas Will Drive Another Growth Surge at NETFLIXProduct Innovation Drives Splunk's 14th STRAIGHT Quarterly Beat
4 Dividend All-Stars to Target As Trade Worries Resurface
Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2018 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter